FFM
Fairmount Funds Management Portfolio holdings
AUM
$772M
This Quarter Return
+2.11%
1 Year Return
+35.05%
3 Year Return
+1,168.51%
5 Year Return
+1,432.11%
10 Year Return
–
AUM
$275M
AUM Growth
+$275M
(+13%)
Cap. Flow
+$15.3M
Cap. Flow
% of AUM
5.56%
Top 10 Holdings %
Top 10 Hldgs %
71.85%
Holding
21
New
2
Increased
7
Reduced
8
Closed
1
Top Buys
| 1 |
Nuvalent
NUVL
|
$20.6M |
| 2 |
Viridian Therapeutics
VRDN
|
$15M |
| 3 |
Tyra Biosciences
TYRA
|
$8.78M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$7.89M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$4.62M |
Top Sells
| 1 |
Astria Therapeutics
ATXS
|
$28.1M |
| 2 |
Amicus Therapeutics
FOLD
|
$8.57M |
| 3 |
Axsome Therapeutics
AXSM
|
$4.12M |
| 4 |
argenx
ARGX
|
$3.17M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$2.87M |
Sector Composition
| 1 | Healthcare | 94.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$28.8B
| $36.2M | 13.16% | 1,313,607 +29,720 | +2% | +$818K |
|
|
ZGNX
2
DELISTED
Zogenix, Inc.
ZGNX
| $29.5M | 10.73% | 1,942,259 -28,000 | -1% | -$425K |
|
|
3
Nuvalent
NUVL
$5.52B
| $20.6M | 7.5% | +914,614 | New | +$20.6M |
|
|
ALLK
4
DELISTED
Allakos
ALLK
| $18.6M | 6.75% | 175,362 +23,200 | +15% | +$2.46M |
|
|
5
Enanta Pharmaceuticals
ENTA
$180M
| $18M | 6.55% | 316,952 +138,894 | +78% | +$7.89M |
|
|
6
argenx
ARGX
$43.6B
| $17.7M | 6.44% | 58,644 -10,500 | -15% | -$3.17M |
|
|
TRIL
7
DELISTED
Trillium Therapeutics Inc.
TRIL
| $15.6M | 5.66% | 886,281 -10,000 | -1% | -$176K |
|
|
8
Viridian Therapeutics
VRDN
$1.5B
| $15.5M | 5.65% | 944,092 +909,000 | +2,590% | +$15M |
|
9
Cogent Biosciences
COGT
$1.69B
| $13.1M | 4.77% | 1,558,975 | – | – |
|
|
AMRN
10
Amarin Corp
AMRN
$311M
| $12.8M | 4.65% | 2,508,237 -25,000 | -1% | -$128K |
|
11
Instil Bio
TIL
$182M
| $12M | 4.38% | 673,905 | – | – |
|
|
12
Iovance Biotherapeutics
IOVA
$807M
| $9.61M | 3.49% | 389,588 -116,302 | -23% | -$2.87M |
|
|
13
Tyra Biosciences
TYRA
$675M
| $8.78M | 3.19% | +499,040 | New | +$8.78M |
|
|
PNT
14
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $8.46M | 3.07% | 1,099,489 +235,275 | +27% | +$1.81M |
|
|
15
Astria Therapeutics
ATXS
$349M
| $8.06M | 2.93% | 911,736 -3,180,430 | -78% | -$28.1M |
|
16
Acadia Pharmaceuticals
ACAD
$4.38B
| $6.92M | 2.52% | 416,817 -7,000 | -2% | -$116K |
|
|
GBT
17
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $6.37M | 2.32% | 250,000 +40,000 | +19% | +$1.02M |
|
|
18
Axsome Therapeutics
AXSM
$6.05B
| $6.18M | 2.25% | 187,598 -125,000 | -40% | -$4.12M |
|
19
Keros Therapeutics
KROS
$618M
| $5.91M | 2.15% | 149,333 | – | – |
|
|
VRNA
20
Verona Pharma
VRNA
$9.16B
| $5.08M | 1.85% | 926,602 +842,658 | +1,004% | +$4.62M |
|
|
21
Amicus Therapeutics
FOLD
$2.34B
| – | – | -888,980 | Closed | -$8.57M |
|